Xu GL - Search Results

1

The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.

Pan JJ, Ge YS, Xu GL, Jia WD, Liu WF, Li JS, Liu WB. Pan JJ, et al. Among authors: xu gl. J Cancer Res Clin Oncol. 2013 Jun;139(6):1043-54. doi: 10.1007/s00432-013-1415-3. Epub 2013 Mar 23. J Cancer Res Clin Oncol. 2013. PMID: 23525579

2

Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma.

Liu W, Xu G, Ma J, Jia W, Li J, Chen K, Wang W, Hao C, Wang Y, Wang X. Liu W, et al. Tohoku J Exp Med. 2011 May;224(1):29-39. doi: 10.1620/tjem.224.29. Tohoku J Exp Med. 2011. PMID: 21512310 Free article.

3

[Expression of Nodal in hepatocellular carcinoma and its relationship with angiogenesis and epithelial-mesenchymal transition].

Chen J, Li J, Liu W, Jia W, Xu G, Ma J. Chen J, et al. Zhonghua Wai Ke Za Zhi. 2014 Mar;52(3):188-92. Zhonghua Wai Ke Za Zhi. 2014. PMID: 24785457 Chinese.

4

High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.

Chen Y, Li L, Qian X, Ge Y, Xu G. Chen Y, et al. Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):190-196. doi: 10.1016/j.clinre.2016.09.010. Epub 2017 Jan 5. Clin Res Hepatol Gastroenterol. 2017. PMID: 28065743

5

Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.

Jia WD, Xu GL, Xu RN, Sun HC, Wang L, Yu JH, Wang J, Li JS, Zhai ZM, Xue Q. Jia WD, et al. Among authors: xu gl, xu rn. J Cancer Res Clin Oncol. 2003 Jun;129(6):327-34. doi: 10.1007/s00432-003-0447-5. Epub 2003 Jun 14. J Cancer Res Clin Oncol. 2003. PMID: 12811549

6

Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma.

Wang W, Jia WD, Xu GL, Wang ZH, Li JS, Ma JL, Ge YS, Xie SX, Yu JH. Wang W, et al. Among authors: xu gl. Dig Dis Sci. 2009 Oct;54(10):2128-36. doi: 10.1007/s10620-008-0605-3. Epub 2008 Dec 4. Dig Dis Sci. 2009. PMID: 19052864

7

Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.

Zhang CH, Xu GL, Jia WD, Ge YS. Zhang CH, et al. Among authors: xu gl. Int J Cancer. 2009 Jun 15;124(12):2982-8. doi: 10.1002/ijc.24311. Int J Cancer. 2009. PMID: 19296539

8

[Prevention of hepatic tumor growth and metastasis in rats with rapamycin].

Wang W, Xu GL, Jia WD, Wang ZH, Li JS, Ma JL, Ge YS. Wang W, et al. Among authors: xu gl. Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):193-7. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19335982 Chinese.

9

A somatostatin analogue, octreotide, inhibits the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice.

Jia WD, Xu GL, Wang W, Wang ZH, Li JS, Ma JL, Ren WH, Ge YS, Yu JH, Liu WB. Jia WD, et al. Among authors: xu gl. Tohoku J Exp Med. 2009 Jun;218(2):155-60. doi: 10.1620/tjem.218.155. Tohoku J Exp Med. 2009. PMID: 19478472 Free article.

10

Can hepatocellular carcinoma be treated by Yondelis through targeting both tumor cells and tumor-associated macrophages?

Zhang CH, Xu GL, Jia WD, Ge YS, Wang W. Zhang CH, et al. Among authors: xu gl. Hepatogastroenterology. 2010 Jan-Feb;57(97):114-6. Hepatogastroenterology. 2010. PMID: 20422884 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters